Key result
In vitro myocardial models enable physiological investigation, disease modeling, and drug toxicity screening.
Why the study?
Cardiomyopathies, heart failure, and arrhythmias stem from cardiomyocyte dysfunction, requiring in vitro myocardial models and analytical techniques to probe physiological functions for basic research, drug discovery, and tissue engineering.
This review highlights advancements in in vitro myocardial models, including various cell types and disease modeling strategies, to improve physiological investigation and therapeutic development.
Advances preclinical platforms for investigation and screening; leaves open clinical translation without prospective validation.
Cardiomyopathies, heart failure, and arrhythmias or conduction blockages impact millions of patients worldwide and are associated with marked increases in sudden cardiac death, decline in the quality of life, and the induction of secondary pathologies. These pathologies stem from dysfunction in the contractile or conductive properties of the cardiomyocyte, which as a result is a focus of fundamental investigation, drug discovery and therapeutic development, and tissue engineering. All of these foci require in vitro myocardial models and experimental techniques to probe the physiological functions of the cardiomyocyte. In this review, we provide a detailed exploration of different cell models, disease modeling strategies, and tissue constructs used from basic to translational research. Furthermore, we highlight recent advancements in imaging, electrophysiology, metabolic measurements, and mechanical and contractile characterization modalities that are advancing our understanding of cardiomyocyte physiology. With this review, we aim to both provide a biological framework for engineers contributing to the field and demonstrate the technical basis and limitations underlying physiological measurement modalities for biologists attempting to take advantage of these state-of-the-art techniques.
No takes yet. Share an insight, caveat, or question.
Callaghan et al. (2019) conducted a review in Cardiomyopathies, heart failure, and arrhythmias. In vitro myocardial models was evaluated. In vitro myocardial models, including primary and stem cell-derived cardiomyocytes, provide essential platforms for physiological investigation, disease modeling, and drug toxicity screening.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: